BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33561698)

  • 1. Experiments and simulation on ZIKV NS2B-NS3 protease reveal its complex folding.
    Kumar A; Kumar P; Aarthy M; Singh SK; Giri R
    Virology; 2021 Apr; 556():110-123. PubMed ID: 33561698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
    Ren J; Lee H; Kotak A; Johnson ME
    Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
    Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
    Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus NS2A-Mediated Virion Assembly.
    Zhang X; Xie X; Xia H; Zou J; Huang L; Popov VL; Chen X; Shi PY
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of molecular interactions between Zika virus protease and peptides derived from the C-terminus of NS2B.
    Li Y; Loh YR; Hung AW; Kang C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):691-696. PubMed ID: 29908184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Structure of the Zika Virus Protease, NS2B/NS3
    Hilgenfeld R; Lei J; Zhang L
    Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
    Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cellular proteome changes in response to ZIKV NS2B-NS3 protease expression.
    Tangsongcharoen C; Roytrakul S; Smith DR
    Biochim Biophys Acta Proteins Proteom; 2019 Feb; 1867(2):89-97. PubMed ID: 30391636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the folding dynamics of NS2B protein of Zika virus.
    Kumar A; Kumar P; Mishra PM; Giri R
    Virology; 2023 Jul; 584():24-36. PubMed ID: 37210794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.
    Chong Teoh T; J Al-Harbi S; Abdulrahman AY; Rothan HA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Spectrometry versus Conventional Techniques of Protein Detection: Zika Virus NS3 Protease Activity towards Cellular Proteins.
    Dabrowska A; Milewska A; Ner-Kluza J; Suder P; Pyrc K
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual function of Zika virus NS2B-NS3 protease.
    Shiryaev SA; Cieplak P; Cheltsov A; Liddington RC; Terskikh AV
    PLoS Pathog; 2023 Nov; 19(11):e1011795. PubMed ID: 38011215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
    Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.
    Cruz KG; Hill Eron M; Makhaik S; Savinov S; Hardy JA
    ACS Infect Dis; 2024 Feb; 10(2):412-425. PubMed ID: 38265226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis autocatalytic cleavage of glycine-linked Zika virus NS2B-NS3 protease constructs.
    von Hammerstein F; Lauth LM; Hammerschmidt S; Wagner A; Schirmeister T; Hellmich UA
    FEBS Lett; 2019 Aug; 593(16):2204-2213. PubMed ID: 31240714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
    Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
    Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.